{
    "id": 31900,
    "fullName": "CYP17A1 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "CYP17A1 positive indicates the presence of the CYP17A1 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1586,
        "geneSymbol": "CYP17A1",
        "terms": [
            "CYP17A1",
            "CPT7",
            "CYP17",
            "P450C17",
            "S17AH"
        ]
    },
    "variant": "positive",
    "createDate": "12/26/2019",
    "updateDate": "12/26/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19631,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, VT-464 treatment improved efficacy over Zytiga (abiraterone) treatment, including increased suppression of Ar activation in CYP17A1-positive, castration-resistant prostate cancer cell lines in culture, and greater tumor growth inhibition and survival in an Xtandi (enzalutamide)-resistant cell line xenograft model (PMID: 25351916).",
            "molecularProfile": {
                "id": 34334,
                "profileName": "CYP17A1 positive"
            },
            "therapy": {
                "id": 2822,
                "therapyName": "VT-464",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17317,
                    "pubMedId": 25351916,
                    "title": "Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25351916"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19630,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Zytiga (abiraterone) treatment suppressed activation of AR in CYP17A1-positive, castration-resistant prostate cancer cell lines in culture, and inhibited tumor growth in an Xtandi (enzalutamide)-resistant cell line xenograft model (PMID: 25351916).",
            "molecularProfile": {
                "id": 34334,
                "profileName": "CYP17A1 positive"
            },
            "therapy": {
                "id": 1805,
                "therapyName": "Abiraterone",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17317,
                    "pubMedId": 25351916,
                    "title": "Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25351916"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34334,
            "profileName": "CYP17A1 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}